Driven by a deep personal connection to cancer care from his mother's battle with the disease, Donnie Rizzo is a passionate leader committed to revolutionizing oncology through technology and compassionate healthcare. As the senior director of oncology and pathology at Quest Diagnostics, he leverages his extensive experience in business development, marketing, commercial operations and finance. His strategic vision has driven digital transformation initiatives and the seamless integration of AI solutions, significantly enhancing operational efficiency and patient outcomes. Before joining Quest Diagnostics, Rizzo held various finance and strategy roles in the diagnostics and pharmaceutical sectors, where he developed his expertise in strategic planning and business development. A recognized expert in digital pathology and AI, he led the successful PathAI acquisition and partnership, reinforcing Quest Diagnostics' leadership in innovative cancer care solutions.

Rizzo earned his Bachelor of Science in Business Administration from Seton Hall University and pursued further education in product design and management at MIT. His educational background, combined with his professional experience, positions him as a thought leader in the intersection of technology and healthcare.

Rizzo fosters a culture of innovation within his teams, empowering them to implement cutting-edge solutions to meet evolving customer needs. He continuously monitors industry trends and leverages data-driven insights to inform strategic decisions, all with the relentless commitment to advancing cancer care and making a meaningful difference in the lives of patients.